Gokce Enguadar is an R&D associate staff at Oak Ridge National Laboratory. She is a part of the University of Tennessee-Oak Ridge Innovation Institute’s Radiopharmaceutical Therapies Convergent Research Initiative. 

Gokce’s research interests include exploring new radionuclides and advancing radiopharmaceutical therapy. At ORNL, she is developing radiopharmaceuticals for nuclear medicine applications. She received her Ph.D. in developing drug delivery methods for therapeutic compounds and imaging agents. Her postdoctoral research with Professor Urs Hafeli at the University of British Columbia focused on evaluating the pharmacokinetics and biodistribution of biomolecules using molecular imaging techniques. She completed her postdoctoral studies in Dr. Paul Schaffer’s research group at TRIUMF, focusing on the development of radioimmunoconjugates – from the production and radiochemical separation of radionuclides to in vivo evaluation.

Before joining ORNL, she was a Research Scientist in Molecular Imaging Program at Stanford (MIPS). 

Education